Yahoo
OTC Markets OTCPK - Delayed Quote USD

Pathfinder Cell Therapy, Inc. (PFND)

0.0001 0.0000 (0.00%)
At close: October 30 at 5:00:00 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
Total Revenue
0
Cost of Revenue
0
Gross Profit
0
Operating Expense
775
Operating Income
-775
Net Non Operating Interest Income Expense
-305
Other Income Expense
0
Pretax Income
-1,080
Net Income Common Stockholders
-1,080
Diluted NI Available to Com Stockholders
-1,080
Basic EPS
0.00
Diluted EPS
0.00
Basic Average Shares
667,161
Diluted Average Shares
667,161
Total Operating Income as Reported
-775
Total Expenses
775
Net Income from Continuing & Discontinued Operation
-1,080
Normalized Income
-1,080
Net Interest Income
-305
EBIT
-775
EBITDA
-772
Reconciled Cost of Revenue
0
Reconciled Depreciation
3
Net Income from Continuing Operation Net Minority Interest
-1,080
Total Unusual Items Excluding Goodwill
0
Total Unusual Items
0
Normalized EBITDA
-772
Tax Rate for Calcs
0
Tax Effect of Unusual Items
0
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: